SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-023426
Filing Date
2023-02-03
Accepted
2023-02-03 08:21:14
Documents
5
Effectiveness Date
2023-02-03

Document Format Files

Seq Description Document Type Size
1 S-8 d419313ds8.htm S-8 55030
2 EX-5.1 d419313dex51.htm EX-5.1 8199
3 EX-23.1 d419313dex231.htm EX-23.1 1510
4 EX-FILING FEES d419313dexfilingfees.htm EX-FILING FEES 14893
5 GRAPHIC g419313g0202053535300.jpg GRAPHIC 2421
  Complete submission text file 0001193125-23-023426.txt   84217
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-269546 | Film No.: 23583790
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences